Healthcare provider profile · identity verified

John Michael Finkner, MD

Family Practice · ALMA, NE · NPI 1922119338

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	523	75
Atorvastatin Calcium	Atorvastatin Calcium	405	59
Omeprazole	Omeprazole	340	50
Amlodipine Besylate	Amlodipine Besylate	312	46
Lisinopril	Lisinopril	284	46
Pantoprazole Sodium	Pantoprazole Sodium	232	30
Tamsulosin Hcl	Tamsulosin Hcl	196	28
Potassium Chloride	Potassium Chloride	188	32
Losartan Potassium	Losartan Potassium	186	25
Metoprolol Tartrate	Metoprolol Tartrate	166	23
Simvastatin	Simvastatin	161	23
Gabapentin	Gabapentin	154	28
Metformin Hcl	Metformin Hcl	151	20
Metoprolol Succinate	Metoprolol Succinate	138	23
Clopidogrel	Clopidogrel Bisulfate	131	19
Lorazepam	Lorazepam	125	34
Carvedilol	Carvedilol	114	18
Furosemide	Furosemide	110	22
Warfarin Sodium	Warfarin Sodium	110	12
Escitalopram Oxalate	Escitalopram Oxalate	99	14
Allopurinol	Allopurinol	98	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	44
Sertraline Hcl	Sertraline Hcl	95	15
Rosuvastatin Calcium	Rosuvastatin Calcium	84	15
Hydrochlorothiazide	Hydrochlorothiazide	83	12
Prednisone	Prednisone	77	40
Montelukast Sodium	Montelukast Sodium	75	14
Meloxicam	Meloxicam	72	12
Pravastatin Sodium	Pravastatin Sodium	72	suppressed
Citalopram Hbr	Citalopram Hydrobromide	67	suppressed
Xarelto	Rivaroxaban	65	11
Tramadol Hcl	Tramadol Hcl	62	25
Spironolactone	Spironolactone	60	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	17
Famotidine	Famotidine	54	suppressed
Jardiance	Empagliflozin	54	suppressed
Atenolol	Atenolol	53	suppressed
Donepezil Hcl	Donepezil Hcl	52	suppressed
Benazepril Hcl	Benazepril Hcl	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	suppressed
Synthroid	Levothyroxine Sodium	40	11
Albuterol Sulfate Hfa	Albuterol Sulfate	39	17
Eliquis	Apixaban	39	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	15
Triamcinolone Acetonide	Triamcinolone Acetonide	39	17
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Baclofen	Baclofen	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Bumetanide	Bumetanide	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Glipizide Er	Glipizide	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Azithromycin	Azithromycin	26	23
Clonidine	Clonidine	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Levofloxacin	Levofloxacin	25	24
Sucralfate	Sucralfate	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Cefdinir	Cefdinir	22	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Novolin R	Insulin Regular, Human	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	11
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Novolin N	Insulin Nph Human Isophane	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	12
Cephalexin	Cephalexin	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Klor-Con M15	Potassium Chloride	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error